Vasant Narasimhan

Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018

Question: Recently, Vasant Narasimhan of Indian origin was appointed Chief Executive Officer (CEO) of which of the following major pharma company?
(a) Ranbaxy Laboratories
(b) Novartis
(c) Lupine
(d) Sunpharma
Answer: (b)
Related Facts:

  • On September 4th, 2017, Vasant Narasimhan of Indian origin was appointed the new Chief Executive Officer (CEO) of the famous Swiss pharma company Novartis.
  • His tenure will begin on February 1, 2018.
  • In present he is Global Head of Drug Development and Chief Medical Officer for Novartis since February 1, 2016.
  • On this post, he will replace Joseph Jimenez.

Reference:
https://www.novartis.com/news/media-releases/novartis-announces-ceo-joseph-jimenez-retire-novartis-2018-vasant-narasimhan
https://www.novartis.com/sites/www.novartis.com/files/cv-vasant-narasimhan-en.pdf